Immunometabolic reprogramming: a working framework for disease development, endotype differentiation, and therapeutic considerations in pediatric asthma

Kaiwen Zheng, Ran Ma, Yingqian Zhang

Open source

DOI
10.3389/fimmu.2026.1999531
Published
2026-10-19
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1999531,
  title = {Immunometabolic reprogramming: a working framework for disease development, endotype differentiation, and therapeutic considerations in pediatric asthma},
  author = {Kaiwen Zheng and Ran Ma and Yingqian Zhang},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1999531},
  url = {https://doi.org/10.3389/fimmu.2026.1999531}
}

RIS

TY  - JOUR
TI  - Immunometabolic reprogramming: a working framework for disease development, endotype differentiation, and therapeutic considerations in pediatric asthma
AU  - Kaiwen Zheng
AU  - Ran Ma
AU  - Yingqian Zhang
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1999531
UR  - https://doi.org/10.3389/fimmu.2026.1999531
ER  - 

APA

Zheng, K., Ma, R., & Zhang, Y. (2026). Immunometabolic reprogramming: a working framework for disease development, endotype differentiation, and therapeutic considerations in pediatric asthma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1999531

Source records